contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


business-update-opdatering-pa-identitetsaendring

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Strategic Partners is a Danish investment company. The company's business concept is to implement strategic partnerships with companies, where the company can take active ownership and create value. In addition to this, investments can also be made in other equity shares and properties to generate returns. Stategic Partners has its headquarters in Herlev.

Strategic Partners

Selskabet annoncerede i selskabsmeddelelse 13/2024, at man havde indledt en proces med at gennemføre et identitetsskifte med Nasdaq for fortsat at kunne bevare sin status som børsnoteret selskab...

Selskabet annoncerede i selskabsmeddelelse 13/2024, at man havde indledt en proces med at gennemføre et identitetsskifte med Nasdaq for fortsat at kunne bevare sin status som børsnoteret selskab. Nasdaq har dags dato meddelt selskabet, at man har modtaget en betinget godkendelse herom, men at den fortsatte børsnotering er betinget af, at man opdaterer selskabets risikobeskrivelse iht. selskabets fremadrettede formål, hvor man udover strategiske partnerskaber indenfor biotek også ønsker at kunne danne partnerskaber i andre brancher samt investere i kapitalandele og ejendomme. Selskabet vil derfor fortsætte processen med Nasdaq ift. at opdatere denne risikobeskrivelse i henhold til Prospektforordningens artikel 16, og såfremt at Nasdaq efterfølgende godkender denne beskrivelse, så vil selskabet i forlængelse heraf indkalde til en ekstraordinær generalforsamling, hvor de relevante godkendelser vil blive foreslået herunder ændring af selskabets formål samt et navneskifte af selskabet. Med venlig hilsen Orphazyme A/S Bestyrelsen For yderligere information, kontakt: Michael Hove, Bestyrelsesformand +45 28126609 Attachment<ul> <li> <a href="https://ml-eu.globenewswire.com/Resource/Download/0929b367-b09e-40e8-91d9-212fc19f21f8">Selskabsmeddelelse 15_2024 Opdatering på identitetsændring</a> </li> </ul><img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMDk5MjU2NSM0MDE5NDY2MzUjMjA5MTE5MQ=="> <img src="https://ml-eu.globenewswire.com/media/Y2JkMzdkYWYtNzgzNC00YWJiLTk3M2EtZjkwNjM2MDQ1NmE5LTExMDI3NjI=/tiny/ORPHAZYME-A-S.png">

Business update - opdatering på identitetsændring:

Probabilities of success in drug development

Return on capital (ROE, ROI, ROIC, RONIC)

Helsinki Stock Exchange is cheap

Drug development investment: Value creation through M&As and licensing agreements

Valuation methods: Valuation multiples

Stay up to date with our newsletter